Docteur Arthur BOUCHUT

Bibliographie

• Cellulosic surfaces endowed with chemical reactivity by physical adsorption of functionalized polysaccharides

  2023

  ArticleCellulose

• ZTE MR-based attenuation correction in brain FDG-PET/MR: performance in patients with cognitive impairment

  2020

  ArticleEuropean Radiology

• Nouveau procédé pour la fonctionnalisation de surface des panneaux à base de bois

  2019

  Thèse

• Modification of the cellulosic surfaces through adsorption of reactive polysaccharides

  2018

  Congrès255th National Meeting and Exposition of the American-Chemical-Society

• Acid-free extraction of cellulose type I nanocrystals using Brønsted acid-type ionic liquids

  2016

  ArticleNanocomposites

Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).

Lieu de consultation

• GHU APHP CUP SITE COCHIN PORT ROYAL

  27 Rue DU FAUBOURG SAINT JACQUES, 75679 Paris 14e Arrondissement

  ☎ 0158414141Hospitalier🏥 Voir cet établissement

Tarifs & secteur de conventionnement

Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).

Prendre rendez-vous & contact

Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).

Top publications · les plus citées

• 1

  ZTE MR-based attenuation correction in brain FDG-PET/MR: performance in patients with cognitive impairment

  European radiology · 2020

  📚 16 citations🎯 RCR 1.47
• 2

  Prognostic value of hypermetabolic bone sarcoidosis observed by 18F-fluorodeoxyglucose positron emission tomography

  Rheumatology (Oxford, England) · 2025

  📚 1 citations🩺 Clinique🔓 Open Access📄 PDF gratuit ↗

  Lire l'abstract Crossref ↓

  Abstract Objectives Sarcoidosis is a multisystemic granulomatosis diagnosed mainly in young adults. 18F-fluorodeoxyglucose (18F-FDG) PET/CT is useful in sarcoidosis cases to search for a biopsiable site or assess disease activity.18F-FDG PET/CT can reveal bone hypermetabolism in sarcoidosis patients, even in the absence of osteoarticular symptoms. The aim of this study was to describe metabolic bone involvement in sarcoidosis patients and to evaluate its prognostic impact. Methods This was an observational, comparative, retrospective, monocentric study. Inclusion criteria were a confirmed diagnosis of sarcoidosis according to the World Association of Sarcoidosis and Other Granulomatous Diseases (WASOG) criteria and at least one 18F-FDG PET/CT scan during follow-up. Metabolic bone involvement of sarcoidosis was defined as focal bone hypermetabolism with no argument for a differential diagnosis of bone 18F-FDG uptake. Patients with and without bone involvement were compared. Results Among the 175 included patients, 32 (18%) had metabolic bone involvement of sarcoidosis. The metabolic bone involvement was mainly axial and mostly without bone abnormalities on CT. Metabolic bone involvement was associated with intrathoracic and extrathoracic lymph node involvement and with a greater number of organs involved. Patients with metabolic bone involvement more frequently received corticosteroids, methotrexate and TNF-α inhibitors and a greater number of treatments. Relapse of sarcoidosis occurred sooner in patients with metabolic bone involvement. Conclusion These results suggest that metabolic bone involvement is associated with more diffuse and more severe sarcoidosis.

• 3

  Imaging of Sacroiliac Joints

  Radiologic clinics of North America · 2024

  📚 1 citations

Publications scientifiques (7) — classées par pathologie

Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).

Partager cette fiche